Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Working Capital/Sales

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.551.531.832.303.11

What is the latest Working Capital/Sales ratio of MARKSANS PHARMA ?

The latest Working Capital/Sales ratio of MARKSANS PHARMA is 1.55 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.55
Mar20231.53
Mar20221.83
Mar20212.30
Mar20203.11

How is Working Capital/Sales of MARKSANS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.55
1.31
Mar2023 1.53
-16.39
Mar2022 1.83
-20.43
Mar2021 2.3
-26.05
Mar2020 3.11 -

Other Financial Ratios of MARKSANS PHARMA


Compare Working Capital/Sales ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹10,840.5 Cr 1.2% -16.2% 61.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,472.0 Cr 0.2% -5.8% 23.9% Stock Analytics
DIVIS LABORATORIES ₹156,342.0 Cr 4.8% 0% 53.8% Stock Analytics
CIPLA ₹114,754.0 Cr -0.2% -4.7% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,465.0 Cr 1.9% -10.9% 0.6% Stock Analytics
ZYDUS LIFESCIENCES ₹96,875.2 Cr 3.2% 0.1% 28.1% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

1.2%

-16.2%

61.6%

SENSEX

1.7%

-2.6%

7.6%


You may also like the below Video Courses